U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
170101170101Pharmacodynamic Effects of Sibutramine on Gastric Function in ObesityCompletedNo Results AvailableObesity|OverweightDrug: sibutraminehttps://ClinicalTrials.gov/show/NCT00330525
170102170102Maternal Hypotension During Cesarean Section and Short Term Neonatal Outcome.TerminatedNo Results AvailableElective Cesarean Section|Maternal Hypotentionhttps://ClinicalTrials.gov/show/NCT00330512
170103170103Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.CompletedNo Results AvailableTransitional Cell Carcinoma of Urinary BladderDrug: Cisplatin|Radiation: External beam radiation treatmenthttps://ClinicalTrials.gov/show/NCT00330499
170104170104Open Label Trial of Acamprosate in Bipolar AlcoholicsCompletedNo Results AvailableAlcohol Dependence|Bipolar DisorderDrug: Acamprosatehttps://ClinicalTrials.gov/show/NCT00330486
170105170105A Concordance Study Comparing Insulin Treatments in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Human Insulin Inhalation Powder|Drug: Insulinhttps://ClinicalTrials.gov/show/NCT00330473
170106170106A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.CompletedHas ResultsOsteoporosis|OsteopeniaDrug: Alendronate|Drug: Denosumabhttps://ClinicalTrials.gov/show/NCT00330460
170107170107Effects of Oncological Treatment During PregnancyRecruitingNo Results AvailableCancer|Pregnancyhttps://ClinicalTrials.gov/show/NCT00330447
170108170108Effect of Ethanol and Genetic Polymorphisms on Bupropion MetabolismCompletedNo Results AvailableAlcohol Drinking|Depression|Smoking Cessation|Attention Deficit DisorderDrug: Bupropion|Drug: Chlorzoxazone|Drug: Ethanolhttps://ClinicalTrials.gov/show/NCT00330434
170109170109Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)CompletedHas ResultsMetastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Metastatic Osteosarcoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Osteosarcoma|Stage I Adult Soft Tissue Sarcoma|StaDrug: sorafenib tosylate|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: computed tomography|Procedure: dynamic contrast-enhanced magnetic resonance imaginghttps://ClinicalTrials.gov/show/NCT00330421
170110170110Impact of Training of GPs on Adherence of Hypertensive Individuals to Antihypertensive MedicationActive, not recruitingNo Results AvailableHypertensionBehavioral: GP traininghttps://ClinicalTrials.gov/show/NCT00330408
170111170111Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)CompletedNo Results AvailableCandidiasisDrug: caspofungin acetatehttps://ClinicalTrials.gov/show/NCT00330395
170112170112Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral LeukoplakiaCompletedHas ResultsLip and Oral Cavity Cancer|Oral Leukoplakia|Oropharyngeal Cancer|Tongue CancerDrug: Bowman-Birk inhibitor concentrate|Other: placebo|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00330382
170113170113DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant HypertensionCompletedNo Results AvailableHypertensionDrug: Darusentan|Drug: Darusentan Placebohttps://ClinicalTrials.gov/show/NCT00330369
170114170114Effects of Low Salt Diet Versus High Salt Diet on Blood PressureActive, not recruitingNo Results AvailableHypertensionBehavioral: Low Salt Diet versus High salt diethttps://ClinicalTrials.gov/show/NCT00330356
170115170115Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/AdolescentsRecruitingNo Results AvailablePain|Nausea|PruritusDrug: naloxonehttps://ClinicalTrials.gov/show/NCT00330343
170116170116Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior TreatmentCompletedNo Results AvailableType 2 Diabetes MellitusDrug: ISIS 113715https://ClinicalTrials.gov/show/NCT00330330
170117170117Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast CancerCompletedNo Results AvailableBreast CancerDrug: letrozolehttps://ClinicalTrials.gov/show/NCT00330317
170118170118Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected ChildrenActive, not recruitingNo Results AvailableTuberculosisDrug: Isoniazid|Drug: Cotrimoxazole|Drug: isoniazid|Other: placebohttps://ClinicalTrials.gov/show/NCT00330304
170119170119Xyrem for Treatment Refractory Insomnia Due to PTSDWithdrawnNo Results AvailablePTSD|Anxiety, Post TraumaticDrug: Xyremhttps://ClinicalTrials.gov/show/NCT00330291
170120170120Timing of Prophylactic Antibiotics for Cesarean SectionsCompletedNo Results AvailableEndometritis|Wound InfectionDrug: Cefazolinhttps://ClinicalTrials.gov/show/NCT00330278
170121170121Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot UlcersRecruitingNo Results AvailableFoot Ulcer|DiabetesDevice: KC-002|Other: Conventional Wound Therapyhttps://ClinicalTrials.gov/show/NCT00330265
170122170122Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLLActive, not recruitingNo Results AvailableChronic Lymphocytic LeukemiaDrug: Rituximab|Drug: Alemtuzumabhttps://ClinicalTrials.gov/show/NCT00330252
170123170123Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance DependenceCompletedNo Results AvailablePTSDDrug: Paroxetine CRhttps://ClinicalTrials.gov/show/NCT00330239
170124170124Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar DisordersRecruitingNo Results AvailableSchizophrenia|Bipolar Disorderhttps://ClinicalTrials.gov/show/NCT00330226
170125170125Effects of Red Wine and Cognac on Coronary CirculationCompletedNo Results AvailableHealthyBehavioral: red wine and cognac consumptionhttps://ClinicalTrials.gov/show/NCT00330213
170126170126Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 DiabeticsTerminatedNo Results AvailableType 2 Diabetes MellitusDrug: ISIS 113715https://ClinicalTrials.gov/show/NCT00330200
170127170127Combined Pharmaco/Behavior Therapy in Adolescent SmokersRecruitingNo Results AvailableNicotine Dependence|Nicotine Use DisorderDrug: Bupropion SR|Behavioral: Contingency Managementhttps://ClinicalTrials.gov/show/NCT00330187
170128170128Acamprosate in Alcoholics With Comorbid Anxiety or DepressionCompletedHas ResultsAlcohol Dependence|Major Depression|Social Anxiety Disorder|Generalized Anxiety DisorderDrug: Acamprosatehttps://ClinicalTrials.gov/show/NCT00330174
170129170129Vorinostat in Treating Patients With Progressive Metastatic Prostate CancerCompletedHas ResultsRecurrent Prostate Cancer|Stage IV Prostate CancerDrug: vorinostat|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00330161
170130170130Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African TrypanosomiasisTerminatedNo Results AvailableTrypanosomiasis, AfricanDrug: melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d|Drug: melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d|Drug: nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7dhttps://ClinicalTrials.gov/show/NCT00330148

* Görseller ve İçerik tekif hakkına sahip olabilir